As of 2026, psilocybin remains a Schedule I controlled substance under federal law. However, several states and cities have decriminalized or legalized it for therapeutic use. Colorado (licensed, supervised use) and Oregon (regulated centers) have active legal frameworks for consumption, while cities like San Francisco, Seattle, and others have decriminalized it.
Federal Status
- Schedule I: Psilocybin and psilocin are classified as having no currently accepted medical use and a high potential for abuse.
- FDA Status: The FDA has designated some psilocybin therapies as “breakthrough therapies,” but it remains federally prohibited outside authorized research.
- Statewide Legal Status (2026)
- Oregon: Legalized in 2020 for supervised, licensed use (Measure 109). By 2026, regulated psilocybin centers are operational, allowing adults to purchase and consume psilocybin under supervision.
- Colorado: Passed Proposition 122 in 2022, decriminalizing personal possession for adults 21+ and establishing licensed “healing centers.” By 2026, these centers are fully operational, with potential expansion to other psychedelics.
- Other States: Many states have introduced legislation for decriminalization or therapeutic research (e.g., California, Massachusetts, Washington), but full statewide legalization is not universal.
Key Local Decriminalization (City Level)
Numerous cities have passed measures to make the possession and cultivation of entheogenic plants and fungi (including psilocybin) the lowest law enforcement priority. These include:
- Detroit, Ferndale, Ann Arbor (MI).
- San Francisco, Oakland, Santa Cruz (CA).
- Seattle, Jefferson County (WA).
- Washington D.C.
- Cambridge, Somerville (MA).
Legal Nuance: Spores
While the fruit (mushrooms) is illegal, spores do not contain psilocybin and are often sold legally online for microscopy purposes in many areas. However, some states, such as Georgia, California, and Idaho, have specific laws against the possession of spores.
